Navigation Links
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Date:8/19/2007

l in the U.S., all patients are eligible to enter a separate open-label extension study in which they will receive XIAFLEX if they were initially given placebo or have other affected joints that need treatment. All patients in these studies will be monitored for a minimum of 12 months following initial dosing for efficacy and safety parameters.

The Australian study is a double-blind, randomized, placebo-controlled study with an open-label extension that will enroll 60 patients. The design of this study is similar to that of the U.S. pivotal phase III trial and its open-label extension.

In addition to the double-blind studies and their open-label extensions, the Company plans to concurrently conduct two phase III open-label studies in approximately 440 patients. These studies will provide additional safety and efficacy data and will contribute to the safety database that is required for the BLA.

"As XIAFLEX is ultimately targeted for worldwide markets, we believe that it is very important to perform well-controlled clinical trials at sites inside and outside of the U.S.," said Dr. Jyrki Mattila M.D., Ph.D., Executive Vice President of R&D, Business Development and Technical Operations. "The Company is eager to raise global physician and patient understanding of the potential benefits of XIAFLEX."

With respect to the clinical program for XIAFLEX for the treatment of Dupuytren's contracture, Auxilium expects to:

- complete enrollment in the pivotal U.S. trial and the Australian trial

by the end of 2007;

- release top-line results from the double-blind phase III clinical trials

in the second quarter of 2008; and

- file the BLA for approval of XIAFLEX by FDA in early 2009.

Conference Call

Auxilium will hold a conference call today, Thursday, August 16, 2007 at 10:00 a.m. Eastern Time. The conference call will be simultaneously web cast on Auxilium's web site and archived for future review until August
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
2. Auxilium Announces New Data That Show Total Testosterone Blood Levels Increase Significantly Following Switch from AndroGel(R) to Testim(R)
3. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
6. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
7. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
8. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
9. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
10. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
11. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering, developing and commercializing innovative therapies addressing major ... of enrollment in its first Phase 2a study, ... confirmed the 1-month findings that were reported in ... - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , , ...
(Date:12/17/2014)... HOUSTON , Dec. 17, 2014 ... Autism Approved ( http://bit.ly/1382OkS ) program seal ... autism community. The program highlights medical practices, materials ... considered "autism-community friendly." Children affected by ... that can be exacerbated by ingredients found in ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "MEMS Gyroscopes Analog Devices ... report to their offering. ... for tactical grade applications made a lot of ... of reliability. They are now accepted in high-reliability ...
Breaking Medicine Technology:RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2
(Date:12/19/2014)... Being in good shape seems to reduce your risk of ... from more than 57,000 Americans, including more than 35,000 with ... 2009. Those in the poorest shape had a more ... the start of the study, compared to a 50 percent ... the more than 8,000 people diagnosed with high blood pressure ...
(Date:12/19/2014)... -- The tragic death from "rat-bite fever" of a 10-year-old ... rodents, according to a report from the U.S. Centers for ... but potentially fatal illness that should be considered in persons ... of rodent exposure is reported," said a team led by ... The case outlined in the report occurred in August of ...
(Date:12/19/2014)... Dotinga HealthDay Reporter ... including ibuprofen, might slightly reduce your risk of developing ... of ibuprofen (Advil, Motrin) and naproxen (Aleve) appear to ... 15 percent, the researchers concluded after reviewing nine prior ... sun exposure. These painkillers "have potential ...
(Date:12/19/2014)... Prostaglandin analogue eye drops -- a common form of ... loss in patients with the eye disease, a new ... of the Moorfields Eye Hospital and UCL Institute of ... people newly diagnosed with open-angle glaucoma -- the most ... leading causes of blindness. About 45 million people ...
(Date:12/17/2014)... Lauderdale, FL (PRWEB) December 17, 2014 While ... many people do not realize the potential dangers of their ... a valid prescription from a qualified doctor, but patients who ... to the point that there is actually no real hCG ... United States, where there are no safety standards and may ...
Breaking Medicine News(10 mins):Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Scratch From Pet Rat Kills Child; CDC Warns of Risk 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3
... Pediatric Patients on What to Expect From Medical ... Conference, Booths #11 & 12 -- GetWellNetwork, ... Care (IPC) solutions, and KidsHealth , the ... introduced two new content suites to their pediatric ...
... Asians with type 2 diabetes are significantly more at risk of ... to White Europeans with the same condition. , A UK ... (damage to the retina) is more prevalent in South Asians and ... , The study, published in the latest issue of Diabetes ...
... for Florida Providers JACKSONVILLE, Fla., March ... information network, announced today an expanded partnership with ... affordable health care to families and individuals. With ... to Molina Healthcare via the Availity secure web ...
... Awards will Honor Significant AchievementALEXANDRIA, Va., March 24 The ... Bricks and Diamonds - on Friday, April 24, ... event applauds those who have advanced hospice and palliative care ... journey at life,s end. Chris Matthews, host of MSNBC,s ...
... Seattle-based organization facilitates blood transfusion services for major ... Wireless, a leading provider of mobile productivity and ... Private Network (VPN) solution has been deployed by ... mobile clinicians with access to wireless data and ...
... Intergy CHC streamlines data collection; simplifies UDS reportingTAMPA, ... a leading provider of integrated electronic health records ... federally qualified health centers (FQHC) nationwide, Sage today ... Health Care, Inc. and HealthLinc, formerly Hilltop Community ...
Cached Medicine News:Health News:GetWellNetwork and KidsHealth(R) Launch New Interactive Patient Education Content for Pediatric Patients and Their Families 2Health News:GetWellNetwork and KidsHealth(R) Launch New Interactive Patient Education Content for Pediatric Patients and Their Families 3Health News:GetWellNetwork and KidsHealth(R) Launch New Interactive Patient Education Content for Pediatric Patients and Their Families 4Health News:South Asians with diabetes more likely to lose their eyesight earlier than white Europeans 2Health News:Availity Expands Partnership with Molina Healthcare 2Health News:National Hospice Foundation Gala to be a Sparkling Celebration 2Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 2Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 3Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 4Health News:Community Health Centers Select Sage Intergy CHC Community Health Management System 2Health News:Community Health Centers Select Sage Intergy CHC Community Health Management System 3Health News:Community Health Centers Select Sage Intergy CHC Community Health Management System 4Health News:Community Health Centers Select Sage Intergy CHC Community Health Management System 5Health News:Community Health Centers Select Sage Intergy CHC Community Health Management System 6
Measles IgM ELISA....
Toxo IgG ELISA. All Wampole ELISA kits include the following: 12 x 8 well strips with breakaway wells, sample diluent, controls and calibrators, conjugate, TMB substrate, wash buffer, stop solution,...
ELISA kit for CMV CAP M....
Cytomegalovirus IgM ELISA....
Medicine Products: